1.Alpha-fetoprotein and its clinical application
Cancer Research and Clinic 2011;23(8):562-565
Alpha-fetoprotein (AFP) was first discovered over 50 years ago, and is currently applied clinically in diagnosis, effects evaluation and relapse judgement of tumors especially for the primary hepatocellular carcinomas.And as an effective tumor marker, AFP test has become one of the essential items in physical examination.However, its clinical application is not limited to primary hepatocellular carcinomas,and its great application value has been proved in many benign diseases and other tumors (non-hepatic carcinomas).
2.Application of fFN and CRP in the evaluation of therapeutic effect for preterm labor.
Chinese Journal of Medical Instrumentation 2015;39(1):77-78
Select 106 pregnant women with threatened preterm labor between 28 and 37 weeks of gestation. They have been treated continually by the preventing preterm labor therapy including antibiotics and magnesium sulfate. Cervicovaginal fetal fibronectin (fFN) and C-reactive protein (CRP) in serum were detected before treatment and after 3-day and 7-day treatment respectively. 100 normal pregnant women were included as control group. (1) The fFN and CRP had significant differences between study group and control group (P<0.05). (2) The fFN and CPR were different compared in the treatment period (P<0.05). Fetal fibronectin and CRP can be used can be used in therapeutic effect evaluation of threatened preterm labor.
C-Reactive Protein
;
analysis
;
Female
;
Fibronectins
;
blood
;
Humans
;
Infant, Newborn
;
Obstetric Labor, Premature
;
diagnosis
;
prevention & control
;
Pregnancy
3.The function of T helper type 17 cell in intestinal mucosal immunity
International Journal of Pediatrics 2011;38(2):155-158
The intestinal mucosa is the biggest lymph organ in human body, which consists of the first line of defensive system with the respiratory mucosa and urinary mucosa. The intestinal mucosa is responsible to defend bacteria, viruses, dietary pathogens, non-steroid anti-inflammatory drug and so on. If the intestinal mucosal immune system is destroyed, the human will suffer many diseases such as infectious diseases,autoimmune diseases. Therefore, it plays an important part in physical health. T helper type 17 (Th17) cells different from Th1 cells and Th2 cells are a distinct lineage of T cells. The discovery of Th17 cells has ruined the constitutional pattern of Th1/Th2. Th17 cells, which are important parts of intestinal mucosal immune system,play critical roles in intestinal autoimmune diseases, tissue inflammation and the infection of various pathogenic bacteria. This paper will review the differentiation of Th17 cell and its function in intestinal mucosal barrier,intestinal autoimmune diseases and intestinal infectious diseases.
4.Prevention and treatment of rotavirus infections in children
International Journal of Pediatrics 2013;(3):261-263
Rotavirus(RV) is the leading pathogen of acute gastroenteritis in children,accounting for approximately 5 % of deaths worldwide.By now,no specific antiviral treatment is available for rotavirus infection.The duration of passive immunization is shorter than active,so oral immunoglobulin for prevention and treatment of rotavirus might not be the best strategy.Currently,two rotavirus vaccines-Rotarix and RotaTeq are licensed and used in many countries,and they have been recognized as powerful weapons to combat deaths from acute gastroenteritis.The trials of interventions,such as oral rehydration,zinc preparations,probiotics and nitazoxanide are testified to be effective for some young children with acute gastroenteritis.This paper reviews the progress of prevention and treatment of rotavirus infections in children.
5.Progress of the genetic research on asthma
International Journal of Pediatrics 2011;38(3):203-206
Bronchial asthma is a chronic inflammatory disorder of the airways,caused by multiple genetic and environmental factors.Thtee key methods including candidate gene study,the positional cloning and genomewide association studies.are used for asthma susceptibility gene identification.There are many candidate genes that haye been identified as asthma susceptibility gene, including ADRB2,IL4R,FLG,NPPA,INPP4A,ADAM33, DPP10,OPN3,0RMDL3,PDE4D,CHBLI etc.Replication of genetic associations and demonstration of a functional mechanism for the associated gene variants are needed to COnfirm an asthmasusceptibility gene, this will help us to understand the aetiology of asthma and explore new drugs to treat asthma.
6.Clinical observation of poractant alfa injection combined with nasal continuous positive airway pressure in the treatment of premature infants with respiratory distress syndrome
Chinese Journal of Primary Medicine and Pharmacy 2016;23(15):2331-2334
Objective To observe the clinical effect of poractant alfa injection(curosurf)combined with nasal continuous positive airway pressure(CPAP)in the treatment of neonatal respiratory distress syndrome(NRDS). Methods Fifty patients of infants with NRDS were divided into 25 cases of observation group(curosurf combined with CPAP)and 25 cases of control group(CPAP)according to the methods of the treatment.The differences in treatment efficacy rate and arterial blood gas index were compared.Results The efficacy rate of the observation group (88%)was higher than that of the control group(56%),the difference between the two groups was statistically significant(χ2 =4.861,P <0.05 ).After the treatment,the arterial blood gas index of the observation group were improved obviously compared with that before the treatment,the differences were statistically significant(all P <0.05).After the treatment,the arterial blood gas index of the control group were improved obviously compared with that before the treatment,the differences were statistically significant(all P <0.05).After treatment,the differences in pH value,PaO2 and PaCO2 of the observation group were statistically significant compared with the control group(t =6.00,8.49,4.46,all P <0.05).Conclusion Poractant alfa injection combined with nasal CPAP in the treatment of NRDS is better than using CPAP alone.
7.Progress of immune status in systemic lupus erythematosus
International Journal of Pediatrics 2012;39(4):390-393
Systemic lupus erythematosus is an autoimmune-mediated inflammatory diseases in which immunologic derangement throughout this process.There are a varriety of abnormal immunoregulation,including the disturbance of Help T cell 1,Help T cell 2,Th17 cell and regulatory T cell( Treg cell),disfunction of the B cell subsets and deficiency of the immune tolerance,lead to the disturbance of related cytokines.Recently,it was indicated that the abnormal of cross regulation existencd between Help T cell 1 and Th17 cell,and the disfunction of non-antibody-dependent B cells may play an important role in the pathogenesis of SLE,According to different immune status,appropriate and targeted treatment was given in order to improve the prognosis of the patients with systemic lupus erythematosus.
8.Expression of VEGF-A and its correlation with the sentinel lympha nodes lymphangiogenesis and metastasis in non-small cell lung cancer
Journal of Chongqing Medical University 2007;0(07):-
Objective: To investigate the expression ofVEGF-Aand the correlation with the sentinel lymph nodes lymphangiogenesis and its metastasis in non-small cell lung cance(rNSCLC).Methods: The expression of VEGF-A was detected in 65 patients with NSCLC by SP immunohistochemistay. The expression of LYVE-1 was detected by immunofluorescence. The new lymphatic vessel density was counted by LYVE-1 and analyzed with clinicopathologic parameters. Results: The positive rate of VEGF-A was 72.3%(47/65),which was positively correlated with sentinel lympha nodes metastasis(r=0.453,P
9.Study on effect of semiconductor quantum dots on growth,invasion and metastasis of human oral osteosarcoma cell line MG-63 in vitro
Journal of Chongqing Medical University 2007;0(12):-
0.05).Conclusion:QDs show no effect on cytobiological behavior of living MG-63 cells.
10.Research on effect of tirofiban on patients with ST-segment elevation acute coronary syndrome ;undergoing intervention treatment
China Medical Equipment 2015;(1):101-103,104
Objective: To analyze the effect of tirofiban on patients with ST-segment elevation acute coronary syndrome undergoing intervention treatment. Methods: Chosen patients with ST-segment elevation acute coronary syndrome between November 2012 to November 2013 as research subjects,randomly assigned to observed group received conventional treatment and control group received tirofiban perioperative, detecting before and after platelet CD40L expression, serum CRP levels, cardiovascular events. Results:1)After treatment, observed group patients platelet CD40L expression intensity was significantly lower than control group(t=3.281, P<0.05);2) at various time points after dosing, serum CRP in observation group were significantly lower than control group patients (t=2.183, t=2.748, t=4.719;P<0.05);3)After treatment, observation group patients cardiovascular event rate was significantly lower than control group(x2=6.493, P<0.05). Conclusion:Perioperative tirofiban therapy can effectively reduce the expression and inflammation in patients with platelet levels, reduce the incidence of adverse cardiovascular events, with positive clinical significance.